Vascular Endothelial Growth Factor Isoform-B Stimulates Neurovascular Repair After Ischemic Stroke by Promoting the Function of Pericytes via Vascular Endothelial Growth Factor Receptor-1
- PMID: 28290152
- DOI: 10.1007/s12035-017-0478-6
Vascular Endothelial Growth Factor Isoform-B Stimulates Neurovascular Repair After Ischemic Stroke by Promoting the Function of Pericytes via Vascular Endothelial Growth Factor Receptor-1
Abstract
Ischemic stroke triggers endogenous angiogenic mechanisms, which correlates with longer survival in patients. As such, promoting angiogenesis appears to be a promising approach. Experimental studies investigated mostly the potent angiogenic factor vascular endothelial growth factor isoform-A (VEGF-A). However, VEGF-A increases the risk of destabilizing the brain microvasculature, thus hindering the translation of its usage in clinics. An attractive alternative VEGF isoform-B (VEGF-B) was recently reported to act as a survival factor rather than a potent angiogenic factor. In this study, we investigated the therapeutic potential of VEGF-B in ischemic stroke using different in vivo and in vitro approaches. We showed that the delayed intranasal administration of VEGF-B reduced neuronal damage and inflammation. Unexpectedly, VEGF-B stimulated the formation of stable brain microvasculature within the injured region by promoting the interaction between endothelial cells and pericytes. Our data indicate that the effects of VEGF-B were mediated via its specific receptor VEGF receptor-1 (VEGFR-1) that is predominately expressed in brain pericytes. Importantly, VEGF-B promoted the survival of pericytes, and not brain endothelial cells, by inducing expression of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2) and the main protein involved in energy homeostasis AMP-activated protein kinase α (AMPKα). Moreover, we showed that VEGF-B stimulated the pericytic release of factors stimulating a "reparative angiogenesis" that does not compromise microvasculature stability. Our study unraveled hitherto unknown role of VEGF-B/VEGFR-1 signaling in regulating the function of pericytes. Furthermore, our findings suggest that brain microvasculature stabilization via VEGF-B constitutes a safe therapeutic approach for ischemic stroke.
Keywords: Angiogenesis; Endothelial cells; Pericytes; Repair; Stroke; VEGF-B; VEGFR-1.
Similar articles
-
VEGF-E Attenuates Injury After Ischemic Stroke by Promoting Reparative Revascularization.Eur J Neurosci. 2025 Apr;61(8):e70114. doi: 10.1111/ejn.70114. Eur J Neurosci. 2025. PMID: 40277075 Free PMC article.
-
Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor.Angiogenesis. 2016 Apr;19(2):133-46. doi: 10.1007/s10456-015-9493-2. Epub 2016 Jan 9. Angiogenesis. 2016. PMID: 26748649
-
In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A.J Histochem Cytochem. 2004 Jan;52(1):39-52. doi: 10.1177/002215540405200105. J Histochem Cytochem. 2004. PMID: 14688216
-
Vascular endothelial growth factors (VEGFs) and stroke.Cell Mol Life Sci. 2013 May;70(10):1753-61. doi: 10.1007/s00018-013-1282-8. Epub 2013 Mar 12. Cell Mol Life Sci. 2013. PMID: 23475070 Free PMC article. Review.
-
Effects of vascular endothelial growth factor in ischemic stroke.J Neurosci Res. 2012 Oct;90(10):1873-82. doi: 10.1002/jnr.23088. Epub 2012 Jun 20. J Neurosci Res. 2012. PMID: 22714747 Review.
Cited by
-
VEGF-E Attenuates Injury After Ischemic Stroke by Promoting Reparative Revascularization.Eur J Neurosci. 2025 Apr;61(8):e70114. doi: 10.1111/ejn.70114. Eur J Neurosci. 2025. PMID: 40277075 Free PMC article.
-
The Role of Pericytes in Ischemic Stroke: Fom Cellular Functions to Therapeutic Targets.Front Mol Neurosci. 2022 Apr 13;15:866700. doi: 10.3389/fnmol.2022.866700. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35493333 Free PMC article. Review.
-
Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.Mol Neurobiol. 2019 Sep;56(9):6521-6538. doi: 10.1007/s12035-019-1539-9. Epub 2019 Mar 9. Mol Neurobiol. 2019. PMID: 30852795
-
Hyperlipidemia in Stroke Pathobiology and Therapy: Insights and Perspectives.Front Physiol. 2018 May 15;9:488. doi: 10.3389/fphys.2018.00488. eCollection 2018. Front Physiol. 2018. PMID: 29867540 Free PMC article. No abstract available.
-
Effect of Pericytes on Cerebral Microvasculature at Different Time Points of Stroke.Biomed Res Int. 2021 Dec 22;2021:5281182. doi: 10.1155/2021/5281182. eCollection 2021. Biomed Res Int. 2021. PMID: 34977241 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials